Abstract:BackgroundThromboembolic events are leading causes of mortality and morbidity all over the world. Tongmai (TM) is a botanical drug with valid clinical efficacy and safety in the management of thrombosis and ischemic cardiovascular diseases, however, its active compounds and underlying mechanism are largely unclear.PurposeTo investigate the endogenous effects, therapeutic mechanism and active compounds of TM in thrombus formation.Study designCombined with transgenic zebrafish models and high-content imaging system, this study evaluated the endogenous antithrombotic effects of TM and screened for the active compounds.MethodsThe PHZ-induced thrombotic model in erythrocytes or platelets labeled transgenic zebrafish were established, to dynamically evaluate the antithrombotic effects of TM. The oxidative damage levels were analyzed by specific fluorescent probes, and the expression levels of key factors in coagulation cascades and platelet activation were examined by QPCR. TM were dissected into fractions by reverse phase chromatography and subsequently screened for their antithrombotic effects in the transgenic fish models. The compounds of the active TM fraction were then analyzed by UPLC-Q-TOF analysis and further verified for their antithrombotic effects and mechanisms.ResultsIn PHZ-induced zebrafish thrombotic model, TM incubation markedly increased cardiac blood flow, decreased peripheral erythrocytes aggregation, and recovered peripheral platelet circulation. Besides, the levels of oxidative stress and lipid peroxidation were increased in the PHZ-induced thrombotic fish, which were greatly decreased by TM treatment. Moreover, TM significantly reduced the expression of coagulation factor II (thrombin) and the downstream fibrinogen. In order to identify the active compounds of TM, four fractions were separated from the extract by reverse phase chromatography, which were subsequently screened for their antithrombotic effects in the fish model. As a result, fraction 4 showed the strongest effect in inhibiting thrombosis. Finally, through UPLC-Q-TOF analysis and endogenous screening, cryptotanshione was identified as the main active compound with antithrombotic effects.ConclusionOur study demonstrated the endogenous antithrombotic effects of TM, which is possibly mediated by inhibiting oxidative stress and coagulation cascade. Cryptotanshione was identified as a major compound with antithrombotic activity and is a promising candidate for novel antithrombotic therapy.

Antiplatelet and antithrombotic activities of timosaponin B-II, an extract of Anemarrhena asphodeloides.

Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review

Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats.

Timosaponin B-Ii Improves Memory And Learning Dysfunction Induced By Cerebral Ischemia In Rats

Identification of Cryptotanshinone from Tongmai to Inhibit Thrombosis in Zebrafish Via Regulating Oxidative Stress and Coagulation Cascade.

Anti-depressive activities and biotransformation of timosaponin B-III and its derivatives

Cardioprotective effect exerted by Timosaponin BII through the regulation of endoplasmic stress-induced apoptosis

Timosaponin B-II Inhibits Pro-Inflammatory Cytokine Induction by Lipopolysaccharide in BV2 Cells

Protective Effects of Timosaponin B-II on High Glucose-Induced Apoptosis in Human Umbilical Vein Endothelial Cells

Anti-Inflammatory Activities Of Compounds Isolated From The Rhizome Of Anemarrhena Asphodeloides

A Rapid and Sensitive Liquid Chromatography–tandem Mass Spectrometric Method for the Determination of Timosaponin B-II in Blood Plasma and a Study of the Pharmacokinetics of Saponin in the Rat

Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters

Timosaponin AIII Disrupts Cell-Extracellular Matrix Interactions through the Inhibition of Endocytic Pathways

Metabolism profile of timosaponin B-II in urine after oral administration to rats by ultrahigh-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.

Timosaponin B-II Ameliorates Palmitate-Induced Insulin Resistance and Inflammation Via IRS-1/PI3K/Akt and IKK/NF-[Formula: See Text]b Pathways.

Cytotoxic steroidal saponins from the rhizome of <i>Anemarrhena asphodeloides</i>

Anti-platelet Activity of Panaxatriol Saponins is Mediated by Suppression of Intracellular Calcium Mobilization and ERK2/p38 Activation

Effect of Toona microcarpa Harms leaf extract on the coagulation system.

Timosaponin B-Ii Ameliorates Diabetic Nephropathy Via Txnip, Mtor, and Nf-Kappa B Signaling Pathways in Alloxan-Induced Mice

Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression